PharmaVoice Logo

Healthcare Leaders Hub

Erasca Reports Updated P-I (AURORAS-1) Data of ERAS-0015 for RAS-Mutant Solid Tumors

PharmaShots

Erasca Reports Updated P-I (AURORAS-1) Data of ERAS-0015 for RAS-Mutant Solid Tumors

Shots: Ref: GlobeNewswire  |   Image: Erasca  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Erasca Reports Updated P-I (AURORAS-1) Data of ERAS-0015 for RAS-Mutant Solid Tumors appeared first on PharmaShots.

Read Full Article
Savara Reports the US FDA Will Not Act on Molgramostim BLA for Autoimmune Pulmonary Alveolar Proteinosis by the PDUFA Date

PharmaShots

Savara Reports the US FDA Will Not Act on Molgramostim BLA for Autoimmune Pulmonary Alveolar Proteinosis by the PDUFA Date

Shots: Ref: Business Wire  |   Image: Savara  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Savara Reports the US FDA Will Not Act on Molgramostim BLA for Autoimmune Pulmonary Alveolar Proteinosis by the PDUFA Date appeared first on PharmaShots.

Read Full Article
Belite Bio Reports Three-Month Extension of the US FDA Review of Tinlarebant NDA for Stargardt Disease Type 1

PharmaShots

Belite Bio Reports Three-Month Extension of the US FDA Review of Tinlarebant NDA for Stargardt Disease Type 1

Shots: Ref: GlobeNewswire  |   Image: Belite Bio  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Belite Bio Reports Three-Month Extension of the US FDA Review of Tinlarebant NDA for Stargardt Disease Type 1 appeared first on PharmaShots.

Read Full Article
Merck’s Sacituzumab Tirumotecan (Sac-TMT) Meets Primary Endpoint of Overall Survival in P-III TroFuse-015 Trial for Gastroesophageal Adenocarcinoma

PharmaShots

Merck’s Sacituzumab Tirumotecan (Sac-TMT) Meets Primary Endpoint of Overall Survival in P-III TroFuse-015 Trial for Gastroesophageal Adenocarcinoma

Shots: Ref: Merck  |   Image: Merck  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Merck’s Sacituzumab Tirumotecan (Sac-TMT) Meets Primary Endpoint of Overall Survival in P-III TroFuse-015 Trial for Gastroesophageal Adenocarcinoma appeared first on PharmaShots.

Read Full Article
Building a Pharma Cleanroom Facility: Why IT Hardware Belongs in the Design Phase

PharmaShots

Building a Pharma Cleanroom Facility: Why IT Hardware Belongs in the Design Phase

When a pharmaceutical or biotech cleanroom is designed, the attention naturally goes to the big systems: the HVAC and its pressure cascade, the room layout and personnel flows, the wall and ceiling panel system, the floor finish and the process equipment. Computers, screens and scanners tend to appear late, often as an item on the… The post Building a Pharma Cleanroom Facility: Why IT Hardware Belongs in the Design Phase appeared first on PharmaShots.

Read Full Article

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

Pharma Tech

Nov 20, 2026, 4:46 PM

Preventative healthcare powers new wave of UK regulatory reform 

Speakers at the 2026 DIA-MHRA Global Summit talked of a healthcare system overhaul with preventative medicine at the core.

PharmaShots

Nov 20, 2026, 4:17 PM

Erasca Reports Updated P-I (AURORAS-1) Data of ERAS-0015 for RAS-Mutant Solid Tumors

Shots: Ref: GlobeNewswire  |   Image: Erasca  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Erasca Reports Updated P-I (AURORAS-1) Data of ERAS-0015 for RAS-Mutant Solid Tumors appeared first on PharmaShots.

PharmaShots

Nov 20, 2026, 4:10 PM

Savara Reports the US FDA Will Not Act on Molgramostim BLA for Autoimmune Pulmonary Alveolar Proteinosis by the PDUFA Date

Shots: Ref: Business Wire  |   Image: Savara  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Savara Reports the US FDA Will Not Act on Molgramostim BLA for Autoimmune Pulmonary Alveolar Proteinosis by the PDUFA Date appeared first on PharmaShots.

PharmaShots

Nov 20, 2026, 4:05 PM

Belite Bio Reports Three-Month Extension of the US FDA Review of Tinlarebant NDA for Stargardt Disease Type 1

Shots: Ref: GlobeNewswire  |   Image: Belite Bio  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Belite Bio Reports Three-Month Extension of the US FDA Review of Tinlarebant NDA for Stargardt Disease Type 1 appeared first on PharmaShots.

PharmaShots

Nov 20, 2026, 4:04 PM

Merck’s Sacituzumab Tirumotecan (Sac-TMT) Meets Primary Endpoint of Overall Survival in P-III TroFuse-015 Trial for Gastroesophageal Adenocarcinoma

Shots: Ref: Merck  |   Image: Merck  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Merck’s Sacituzumab Tirumotecan (Sac-TMT) Meets Primary Endpoint of Overall Survival in P-III TroFuse-015 Trial for Gastroesophageal Adenocarcinoma appeared first on PharmaShots.

Pharma Tech

Nov 20, 2026, 2:59 PM

MSD and Isomorphic join forces to develop oncology drugs 

MSD inks this deal as it looks to offset the looming impact of Keytruda’s patent expiry and secure its long-term growth prospects.

News

Latest industry coverage

Google News

Nov 21, 2026, 6:28 PM

NCB busts interstate pharma drugs syndicate - The Times of India

NCB busts interstate pharma drugs syndicate  The Times of India

Google News

Nov 21, 2026, 5:32 PM

Delhi Health Minister Urges US Healthcare Companies To Bring Affordable Technologies To India - BW Healthcare World

Delhi Health Minister Urges US Healthcare Companies To Bring Affordable Technologies To India  BW Healthcare World

Google News

Nov 21, 2026, 5:13 PM

Ipca Labs to Shut Mahad Drug Intermediates Unit, Sell Property for Rs 16.90 Crore - Medical Dialogues

Ipca Labs to Shut Mahad Drug Intermediates Unit, Sell Property for Rs 16.90 Crore  Medical Dialogues

Google News

Nov 21, 2026, 5:10 PM

Little Green Pharma And 2 Australian Biotech Stocks To Watch - Yahoo Finance

Little Green Pharma And 2 Australian Biotech Stocks To Watch  Yahoo Finance

Google News

Nov 21, 2026, 5:02 PM

Gland Pharma Names Ajay Sahni President of French Subsidiary Phixen SAS - Medical Dialogues

Gland Pharma Names Ajay Sahni President of French Subsidiary Phixen SAS  Medical Dialogues

Google News

Nov 21, 2026, 4:50 PM

Maharashtra FDA Tightens Rules for Pharmacies, Gyms Selling Supplements, Seizes Rs 1.38 Crore Stock - Medical Dialogues

Maharashtra FDA Tightens Rules for Pharmacies, Gyms Selling Supplements, Seizes Rs 1.38 Crore Stock  Medical Dialogues

Google News

Nov 21, 2026, 4:30 PM

AbbVie, Disco Pharma Strike USD 2.54 Billion Cancer Drug Development Deal - Medical Dialogues

AbbVie, Disco Pharma Strike USD 2.54 Billion Cancer Drug Development Deal  Medical Dialogues

Google News

Nov 21, 2026, 3:15 PM

The Reputation Leaders 100: India’s Most Influential Healthcare Communications Leaders – 2026 - Indian Startup Times

The Reputation Leaders 100: India’s Most Influential Healthcare Communications Leaders – 2026  Indian Startup Times

Google News

Nov 21, 2026, 2:46 PM

Healthcare Visual Inspection Services Market Size, 2034 - Fortune Business Insights

Healthcare Visual Inspection Services Market Size, 2034  Fortune Business Insights

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer